Recent

% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

  • tjnelis tjnelis Sep 14, 2011 11:54 AM Flag

    FDA and incy 424

    based on the time frame, the fda has until the 1st of October to contact Incyte and meet with them and an advisory committe/board....if not based on a based a past results of 2 other drugs , one by pfizer, 424 will be approved, and more than likely before DEC-3....as per the morgan stanley call today

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think there is a chance that ruxolitinib will be approved before the PDUFA date. It may not extend patients' lives like vemurafenib and crizotinib do, but IMO there is a clear improvement in patients' quality of life. When you also consider that there are no comparable treatment options out there for MF, I think there is a strong rationale more making the drug available ASAP.

 
INCY
107.34-0.51(-0.47%)Apr 24 4:00 PMEDT